CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy: Proteins in the CSF of seropositive CIDP patients show probable blood-brain barrier breakdown, which could increase the likelihood of anti-CNTN1 antibodies entering the brain parenchyma (163, 178).